Straits Times Index
3,330.77 -0.04 (-0.00%) Nikkei
38,683.93 -19.58 (-0.05%) Hang Seng
18,366.95 -109.85 (-0.59%) FTSE 100
8,245.37 -39.97 (-0.48%) Bitcoin USD
69,354.93 +320.33 (+0.46%) CMC Crypto 200
1,443.28 -35.42 (-2.40%)
EW Jun 2024 95.000 call
| Previous close | 0.1500 |
| Open | 0.1100 |
| Bid | 0.0500 |
| Ask | 0.1500 |
| Strike | 95.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.1000 - 0.1100 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.7k |
ZacksBD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
Business WireFive-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical
Simply Wall St.Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
